Crossref


3. Case Report: Dual resistance to dasatinib/olverembatinib in accelerated-phase cml: identification of a novel SPECC1L-inserted e8a2 BCR::ABL1 transcript and ABL1 V379I mutation

- Jingjing Fu

- Yangming Tang

- Xueqin Ruan

- Runfa Wang

- Tong Chen

- Li Jiang

- Yanli He

- Zhihong Xu

- Balian Wang

- Haiqin Zhang

- Jing Zhou

- Mei Lan

- Hongrui Li

4. Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India

- Gautam Hazarika

- Manash Jyoti Kalita

- Partha Pratim Das

- Simanta Kalita

- Kalpajit Dutta

- Lipika Lahkar

- Anjanjyoti Rajkonwar

- Mohammed Ghaznavi Idris

- Vinotsale Khamo

- Giriraj Kusre

- Subhash Medhi

5. Novel ABL1 mutation in a Moroccan CML patient with Imatinib resistance

- Ihssane El Bouchikhi

- Hajar Azami Idrissi

- Ahmed Lazraq

- Badreddine El Makhzen

- Mohamed Ahakoud

- Rhizlane Berrady

- Karim Ouldim

- Laila Bouguenouch

- Mohammed El-Azami-El-Idrissi

6. Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia

- Alyaa Mohamed Ghoneem

- Eman A. Soliman

- Shaimaa El-Ashwah

- Mohammed El Agdar

- Hasan Abdel-Ghaffar

8. BCR-ABL Kinase Domain mutations - E255K, Y253 H and M351T among Sudanese population with CML

- Hala Elsir Khair

- Abozer Yousif Elderdery

- Bakri Yousef Nour

- Hadeil Mohamed Elamin Idris

- Gamila Ali Attaelmanan

- Babker Ahmed Mohamed

- Hisham Ali Waggiallah

9. Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181

- Jiangjiang Gong

- Shunli Zheng

- Lei Zhang

- Yi Wang

- Jiali Meng